Avutometinib
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer (NCT07318324) | M.D. Anderson Cancer Center | 2026-05-13 |
Track Avutometinib automatically
Every clearance here is in the API, with alerts when new ones post.